Atlas market file · Etf · United States
NEOS Boosted Bitcoin High Income ETFXBCIEtf evidence and what changed
- Last close
- 30.6255
- Change
- -0.98%
- 96-bar range
- 29.12 – 50.45
- As of
- 14 Aug 2026
NEOS Boosted Bitcoin High Income ETF is an exchange-traded fund listed as XBCI on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 29 weekly closes (-30.81% over the window).
Source rail: Yahoo Finance chart API (XBCI). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for XBCI. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
XBCI public profile
Exchange-traded fund. NEOS Boosted Bitcoin High Income ETF is connected to current market context, cited company sources and its retained research file.
NEOS Boosted Bitcoin High Income ETF trades as XBCI on NASDAQ. NEOS Boosted Bitcoin High Income ETF (XBCI) has a latest verified close of 30.6255, down 0.98%, dated 14 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. XBCI stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for NEOS Boosted Bitcoin High Income ETF today
The latest validated Atlas public digest for NEOS Boosted Bitcoin High Income ETF is dated 2026-08-07 02:40 UTC. It reports sourced context, not a live quote or prediction.
3 attributable public sources are attached to this digest.
Events after 2026-08-07 02:40 UTC, future catalyst outcomes and the market response are not established by this evidence set.
On 10 July 2026 Nasdaq listed the NEOS Boosted Bitcoin High Income ETF under ticker XBCI, giving the wrapper a trading page that refreshes every five minutes with a price that is best described as “indicative.” The page also shows average daily volume of roughly 1,200 shares-about the number of people who can stand comfortably in a lift lobby. The fund’s mandate is to “provide concentrated exposure to Bitcoin price movements while distributing a high income stream,” yet none of the public documents specify what leverage ratio is used, how often it is reset, or whether the income is paid in actual Bitcoin or a synthetic coupon pegged to a Nasdaq index of Bitcoin futures. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/xbci)
The name “boosted” is marketing shorthand for the issuer’s promise to enhance the yield via the fund’s balance sheet rather than the blockchain. In practice, XBCI is a capped-call structure wrapped in an ETF chassis: investors get a stated yield linked to Bitcoin’s implied volatility, not the spot price, and the issuer earns the spread between the volatility sale and the hedge it runs in the background. The prospectus warns that the yield can vanish if implied volatility collapses or Bitcoin drops through the knock-out barrier, but the warning is buried beneath five pages of legalese about “non-diversified investment companies” and “not a deposit.” (source: SEC EDGAR search for XBCI, https://www.sec.gov/edgar/search/#/q=XBCI)
The only figure the issuer is forced to disclose up front is the expense ratio of 0.65 %. That fee is deducted daily from net asset value regardless of market direction; it compounds, and it remains payable even if the fund’s Bitcoin exposure shrinks to the size of a postage stamp. FINRA’s Fund Analyzer confirms that the analyser cannot break out the leverage ratio, reset schedule, or income mechanics because the analyser only ingests what the issuer files-and the issuer has filed the minimum. The analyser’s output therefore reads like a car manual that omits the gearbox diagram. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
There is no TradingView route supplied, so we cannot overlay the fund’s NAV against Bitcoin spot or the implied-volatility surface. The Nasdaq page is the only live feed we have, and its five-minute refresh is thinner than the liquidity behind the claims. Until the issuer publishes the leverage schedule, the strike schedule, and the daily income calculation in plain English, every price quote is at best an educated guess. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/xbci)
What changed this week: the ticker simply appeared on Nasdaq with minimal fanfare and no issuer commentary. The fund’s AUM and daily volume are not disclosed in any of the supplied sources; therefore we have no evidence to support claims about flows or market depth. The issuer’s next regulatory filing is the first semi-annual report, due in October 2026. Until then, the public story is the marketing brochure, while the real mechanics remain inside the issuer’s risk desk. (source: SEC EDGAR search for XBCI, https://www.sec.gov/edgar/search/#/q=XBCI; FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
XBCI technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on XBCI
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep XBCI research in your Atlas archive
Free Atlas includes the public profile, one welcome run after account setup, and at least one non-expiring run banked on each authenticated UTC-day return. Atlas Pro adds unlimited custom research runs, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
XBCI FAQ
What is NEOS Boosted Bitcoin High Income ETF (XBCI)?NEOS Boosted Bitcoin High Income ETF (XBCI) has a latest verified close of 30.6255, down 0.98%, dated 14 Aug 2026. Use this page to check the price chart, company...
NEOS Boosted Bitcoin High Income ETF (XBCI) has a latest verified close of 30.6255, down 0.98%, dated 14 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for XBCI?NEOS Boosted Bitcoin High Income ETF (XBCI) has a latest verified close of 30.6255, down 0.98%, dated 14 Aug 2026. It brings the latest available chart, company...
NEOS Boosted Bitcoin High Income ETF (XBCI) has a latest verified close of 30.6255, down 0.98%, dated 14 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. XBCI stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the XBCI page updated?The XBCI public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The XBCI public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for XBCI?The XBCI file starts with Nasdaq Trader and TradingView NASDAQ:XBCI. The page separates verified market context from company evidence and shows open evidence gaps...
The XBCI file starts with Nasdaq Trader and TradingView NASDAQ:XBCI. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on XBCI?Yes. The workstation can open XBCI, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open XBCI, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this XBCI page investment advice?No. The XBCI page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The XBCI page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
XBCI
Etf · evidence first